So many new treatments on the horizon: voclosporin, anifrolumab, belimumab for LN. The year of the wolf 🐺
#Lupus https://t.co/uDzIzU0pvK
Links:
NEJM on Twitter: "A phase 3 trial of anifrolumab showed benefit in a compo…
https://twitter.com/NEJM/status/1207422788413227008
Dec-20-2019
